Geneva, Oct. 8 -- International Clinical Trials Registry received information related to the study (ISRCTN15356736) titled 'A randomized trial of disulfiram and zinc administered together to treat diarrhea caused by Entamoeba histolytica' on Sept. 24.
Study Type: Interventional
Study Design:
Randomized controlled trial (Treatment)
Primary Sponsor: University of Florida
Condition:
Symptomatic diarrhea due to E. histolytica
Infections and Infestations
Intervention:
Participants who meet all eligibility criteria and consent to participation will be randomized to receive either low dose disulfiram (250 mg) daily plus 50 mg zinc gluconate thrice daily x 10 days
Recruitment Status: Recruiting
Phase: Phase II
Date of First Enrollme...